IPO registrations (S-1, F-1) · Registrants

TransMedics Group, Inc.

SEC CIK
1756262 · filings on EDGAR ↗
Registration
Form S-1, first filed 2019-04-05, last 2019-05-01; 1 initial registration, 3 amendments
Outcome
Final prospectus filed 2019-05-02; declared effective 2019-05-01
Industry (SIC)
Electromedical & Electrotherapeutic Apparatus 3845
Incorporated in
MA
Business address
200 MINUTEMAN ROAD, Andover, MA 01810
Ticker
TMDX (Nasdaq)
EDGAR entity type
operating
Insiders and CEO pay
TransMedics Group, Inc. on the corporate pages

Offering terms

Proposed price range
$15.00–$17.00 per share (S-1/A filed 2019-05-01)
Final price
$16.00 per share, within the range (424B4 filed 2019-05-02, an initial public offering)
Shares sold
5,690,000
Gross proceeds
$91,040,000 before underwriting discounts and any over-allotment option
Listing
Nasdaq under the symbol TMDX
Lead underwriters
Morgan Stanley; J.P. Morgan
Syndicate
Cowen; Canaccord Genuity

Read from the cover pages of the filings listed under “Prospectus pages read” below; check the document for anything that matters.

Filings 8

FiledFormWhat it isName as filedEDGAR
2019-04-05S-1S-1 (registration)TransMedics Group, Inc.0001193125-19-099213 ↗
2019-04-22S-1/AS-1/A (amendment)TransMedics Group, Inc.0001193125-19-112722 ↗
2019-04-30S-1/AS-1/A (amendment)TransMedics Group, Inc.0001193125-19-126462 ↗
2019-05-01S-1/AS-1/A (amendment)TransMedics Group, Inc.0001193125-19-130580 ↗
2019-05-01S-1MEFS-1MEF (added securities)TransMedics Group, Inc.0001193125-19-133517 ↗
2019-05-01EFFECTEFFECT (declared effective)TransMedics Group, Inc.9999999995-19-000980 ↗
2019-05-02424B4424B4 (final prospectus)TransMedics Group, Inc.0001193125-19-135109 ↗
2020-05-21EFFECTEFFECT (declared effective)TransMedics Group, Inc.9999999995-20-001235 ↗

Prospectus pages read 2

FiledFormRead asRangePriceSharesProceedsListingUnderwritersWhat was foundDocument
2019-05-01S-1/Aregistration statement$15.00–$17.004,700,000-Nasdaq TMDX4primary document; range, shares headline, cover names 4document ↗
2019-05-02424B4final prospectus$16.005,690,000$91,040,000Nasdaq TMDX4primary document; price sentence, shares headline, proceeds table, cover names 4document ↗

Officers, directors and large holders Forms 3, 4 and 5

InsiderRoleTitleFilingsYearsOn this site
ABRAMS CAPITAL, LLCTenPercentOwner32019–2021
ABRAMS CAPITAL MANAGEMENT, LLCTenPercentOwner32019–2021
ABRAMS CAPITAL MANAGEMENT, L.P.TenPercentOwner32019–2021
Abrams Capital Partners II, L.P.TenPercentOwner32019–2021
Abrams David CTenPercentOwner32019–2021
AFEYAN NOUBARTenPercentOwner32019
Basile Edward MDirector202019–2026
Carey John FOfficerVP of Operations402019–2023
Flagship Ventures 2007 General Partner LLCTenPercentOwner32019
Flagship Ventures Fund 2007, L.P.TenPercentOwner32019
Flagship Ventures Fund IV General Partner LLCTenPercentOwner32019
Flagship Ventures Fund IV, L.P.TenPercentOwner32019
Gilbert JamesDirector12019
Gordon StephenOfficerChief Financial Officer372019–2024
Gunderson Thomas J.Director102019–2026
Hassanein Waleed HDirector,OfficerPresident & CEO532019–2026
Kania EdwinDirector132019–2026
Khayal Tamer IOfficerChief Commercial Officer552019–2025
Lung Biotechnology PBCTenPercentOwner32019
Provost MiriamOfficerVP, Global Regulatory Affairs; VP of Global Regl. Affairs; VP of US Regulatory & FDA Rel.142019–2023
Riva Capital Management III, LLCTenPercentOwner32019–2021
Riva Capital Partners III, L.P.TenPercentOwner32019–2021
Sullivan John FOfficerVP of Quality & Engineering112019–2021
TOBIN JAMES RDirector222019–2026
UNITED THERAPEUTICS CorpTenPercentOwner32019
Weill DavidDirector172019–2026
DAMME LAURAOfficerVP, Clinical Affairs72019–2023
RAINES MERILEEDirector82021–2026
Lovell StephanieDirector102021–2026
Godhani Rakesh P.OfficerChief Digital Officer22021
Corcoran NicholasOfficerSee remarks; See Remarks82023–2026
Ranganath Anil P.OfficerSee remarks; See Remarks72023–2026
Hernandez GerardoOfficerChief Financial Officer62024–2026
Cecere GiovanniOfficerChief Commercial Officer32026
Forsyth Matthew S.OfficerSee Remarks22026
Araujo Fernando N.OfficerSee Remarks12026

Everyone who filed an insider report for this company, from the SEC’s Insider Transactions Data Sets (2006 on). Person pages are matched by name and state only.

Data: SEC EDGAR. The quarterly full index (every S-1, S-1/A, F-1 and F-1/A since 1993, with the pricing prospectus, notice of effectiveness and withdrawal request of each registrant) and the company submissions data (SIC, state of incorporation, address, EIN, tickers, former names). Company details are what EDGAR holds today, not at the time of the filing.

Also on this site Fuzzy

RecordName as filedWhereDatasetMatched by
IPO registrantTransMedics, Inc.MAIPO registrations (S-1, F-1)same street address and ZIP code, 200 MINUTEMAN RD 01810 (FUZZY: a shared address, not proof of a shared organization)
Lobbying clientTRANSMEDICS GROUP, INC.MAFederal lobbying (LDA)name and state
SEC filerTransMedics Group, Inc.SEC filers (EDGAR)CIK (EXACT)

Matched by an identifier (EIN, CIK, CRD), by name and state or city, or by street address; a shared name or address is not proof of the same person or organization. Every link says how it was made; how the cross-referencing works.

Others with the same interests

SIC industry Electromedical & Electrotherapeutic Apparatus, MA first:

More with this interest.

In other datasets, the same topic (Technology) in MA:

Interests: Electromedical & Electrotherapeutic Apparatus · Technology